Liver disease: NAFLD (30.1%); baseline AST/ALT >2x ULN only (12.5%); alcohol (4.2%); viral hepatitis (19.8%); cirrhosis (1.8%); congestive hepatopathy (1.7%); others (29.6%). This evidence concerns the gene GPT and animal viral hepatitis.